Studies have shown the importance of co-stimulation of both CD8+ and CD4 + T-cells for both spontaneous and immunotherapy-triggered anti-tumour immune responses and for circumventing immune tolerance of cancer cells [38,55,56]. The gene discussed is CD4; the disease is cancer.